Sanofi has said its radioligand therapy (RLT) for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) hit all its objectives in a phase 2 study, setting up possible regulatory filings. The ...
User's Guide Published: September 2003 Question 6 How would one retrieve the sequence of a gene, along with all annotated exons and introns, as well as a certain number of flanking bases for use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback